Monday 1 July 2024

The Pharma Letter Podcast — Episode 15 — Can AI find new drugs for metabolic diseases?

Pharmaceutical
4 July 2022
episode15-big

More on this story...

Pharmaceutical
European drugmakers embrace artificial intelligence
3 December 2020
Pharmaceutical
Is AI patentable?
5 July 2022
Pharmaceutical
Industry spending on AI set to reach $3 billion by 2025
8 July 2022
Biotechnology
AbCellera and Rallybio link up on antibodies for rare diseases
1 December 2022


Related Company News

Understanding the AI-enabled drug discovery landscape
More ones to watch >


Today's issue

Pharmaceutical
Boosting crinecerfont, Neurocrine draws from gamut of FDA support
1 July 2024
Biotechnology
Forbion expands to Boston, hires former Dyne CEO
1 July 2024
Pharmaceutical
In ALS, Phase II data show two drugs could be better than one
1 July 2024
Biotechnology
Another win for nipocalimab as J&J closes in on rivals
1 July 2024
Pharmaceutical
Merck & Co sees value in novel prostate cancer drug
1 July 2024
Biotechnology
New Ajovy data challenges treatment breaks in migraine prevention
1 July 2024
Biotechnology
Zenas BioPharma appoints Orlando Oliveira as CCO
1 July 2024

Company Spotlight

A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.




More Features in Pharmaceutical

Boosting crinecerfont, Neurocrine draws from gamut of FDA support
1 July 2024
In ALS, Phase II data show two drugs could be better than one
1 July 2024
Merck & Co sees value in novel prostate cancer drug
1 July 2024
Lonza welcomes new CEO Wolfgang Wienand
1 July 2024


Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze